Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
2.
J Nutr Health Aging ; 25(4): 440-447, 2021.
Article in English | MEDLINE | ID: mdl-33786560

ABSTRACT

BACKGROUND: The COVID-19 pandemic has led to abrupt restrictions of life-space mobility. The impact of shelter-in-place orders on older adults' health and well-being is still unclear. OBJECTIVE: To investigate the relationship between life-space mobility and quality of life (QoL) in older adults with and without frailty during the COVID-19 pandemic. DESIGN: Multicenter prospective cohort study based on structured telephone interviews. SETTING: Four geriatric outpatient clinics in the metropolitan area of Sao Paulo, Brazil. PARTICIPANTS: 557 community-dwelling adults aged 60 years and older. MEASUREMENTS: The Life-Space Assessment was used to measure community mobility before and during the COVID-19 pandemic, and a previously validated decrease of ≥ 5 points defined restricted life-space mobility. Frailty was assessed through the FRAIL (fatigue, resistance, ambulation, illnesses, and loss of weight) scale. The impact of shelter-in-place orders on QoL was evaluated with the question «How is the COVID-19 pandemic affecting your QoL?¼, to which participants could respond «not at all¼, «to some extent¼, or «to a great extent¼. We used ordinal logistic regressions to investigate the relationship between restricted life-space mobility and impact on QoL, adjusting our analyses for demographics, frailty, comorbidities, cognition, functionality, loneliness, depression, and anxiety. We explored whether frailty modified the association between life-space mobility and impact on QoL. RESULTS: Participants were on average 80±8 years old, 65% were women, and 33% were frail. The COVID-19 quarantine led to a restriction of community mobility in 79% of participants and affected the QoL for 77% of participants. We found that restricted life-space mobility was associated with impact on QoL in older adults during the pandemic, although frailty modified the magnitude of the association (P-value for interaction=0.03). Frail participants who experienced restricted life-space mobility had twice the odds of reporting an impact on QoL when compared with non-frail individuals, with respective adjusted odds ratios of 4.20 (95% CI=2.36-7.50) and 2.18 (95% CI=1.33-3.58). CONCLUSION: Older adults experienced substantial decreases in life-space mobility during the COVID-19 pandemic, and this unexpected change impacted their QoL. Providers should be particularly watchful for the consequences of abrupt life-space restrictions on frail individuals.


Subject(s)
COVID-19/psychology , Frail Elderly/psychology , Frailty/psychology , Geriatric Assessment/statistics & numerical data , Quality of Life/psychology , Aged , Aged, 80 and over , Anxiety/psychology , Brazil , Cross-Sectional Studies , Depression/psychology , Fatigue/psychology , Female , Humans , Independent Living , Interviews as Topic , Loneliness/psychology , Male , Middle Aged , Physical Distancing , Prospective Studies , SARS-CoV-2
3.
São Paulo; Manole; 2020. 329 p.
in Portuguese | DANTEPAZZANESE, SESSP-IDPCACERVO | ID: dan-4880
4.
Braz J Med Biol Res ; 51(3): 1-8, 2018 Jan 23.
Article in English | MEDLINE | ID: mdl-29513883

ABSTRACT

Particles are usually polydispersed and size is an important feature for lipid-based drug delivery systems in order to optimize cell-particle interactions as to pharmacologic action and toxicity. Lipid nanoparticles (LDE) with composition similar to that of low-density lipoprotein carrying paclitaxel were shown to markedly reduce atherosclerosis lesions induced in rabbits by cholesterol feeding. The aim of this study was to test whether two LDE fractions, one with small (20-60 nm) and the other with large (60-100 nm) particles, had different actions on the atherosclerotic lesions. The two LDE-paclitaxel fractions, prepared by microfluidization, were separated by density gradient ultracentrifugation and injected (4 mg/body weight, intravenously once a week) into two groups of rabbits previously fed cholesterol for 4 weeks. A group of cholesterol-fed animals injected with saline solution was used as control to assess lesion reduction with treatment. After the treatment period, the animals were euthanized for analysis. After treatment, both the small and large nanoparticle preparations of LDE-paclitaxel had equally strong anti-atherosclerosis action. Both reduced lesion extension in the aorta by roughly 50%, decreased the intima width by 75% and the macrophage presence in the intima by 50%. The two preparations also showed similar toxicity profile. In conclusion, within the 20-100 nm range, size is apparently not an important feature regarding the LDE nanoparticle system and perhaps other solid lipid-based systems.


Subject(s)
Atherosclerosis/drug therapy , Lipids/administration & dosage , Lipoproteins, LDL/drug effects , Nanoparticles/administration & dosage , Paclitaxel/administration & dosage , Tubulin Modulators/administration & dosage , Animals , Drug Therapy, Combination , Male , Particle Size , Rabbits
5.
Braz. j. med. biol. res ; 51(3): 7090, 2018. tab, graf
Article in English | LILACS | ID: biblio-889042

ABSTRACT

Particles are usually polydispersed and size is an important feature for lipid-based drug delivery systems in order to optimize cell-particle interactions as to pharmacologic action and toxicity. Lipid nanoparticles (LDE) with composition similar to that of low-density lipoprotein carrying paclitaxel were shown to markedly reduce atherosclerosis lesions induced in rabbits by cholesterol feeding. The aim of this study was to test whether two LDE fractions, one with small (20-60 nm) and the other with large (60-100 nm) particles, had different actions on the atherosclerotic lesions. The two LDE-paclitaxel fractions, prepared by microfluidization, were separated by density gradient ultracentrifugation and injected (4 mg/body weight, intravenously once a week) into two groups of rabbits previously fed cholesterol for 4 weeks. A group of cholesterol-fed animals injected with saline solution was used as control to assess lesion reduction with treatment. After the treatment period, the animals were euthanized for analysis. After treatment, both the small and large nanoparticle preparations of LDE-paclitaxel had equally strong anti-atherosclerosis action. Both reduced lesion extension in the aorta by roughly 50%, decreased the intima width by 75% and the macrophage presence in the intima by 50%. The two preparations also showed similar toxicity profile. In conclusion, within the 20-100 nm range, size is apparently not an important feature regarding the LDE nanoparticle system and perhaps other solid lipid-based systems.


Subject(s)
Animals , Male , Rabbits , Paclitaxel/administration & dosage , Atherosclerosis/drug therapy , Tubulin Modulators/administration & dosage , Nanoparticles/administration & dosage , Lipids/administration & dosage , Lipoproteins, LDL/drug effects , Particle Size , Drug Therapy, Combination
6.
Exp Clin Endocrinol Diabetes ; 123(4): 232-9, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25658661

ABSTRACT

OBJECTIVE: Investigate the relations of glycemic levels with plasma lipids and in vitro lipid transfers to HDL in patients with type 2 diabetes mellitus. MATERIALS AND METHODS: 143 patients with type 2 diabetes not taking anti-lipidemic drugs were separated into 2 groups: group A included 62 patients with glycated hemoglobin (HbA1c)≤6.5% (48 mmol/mol) and group B 81 patients with HbA1c>6.5%. In vitro transfer of lipids was determined by 1 h incubation of a donor nanoemulsion containing radioactively labeled unesterified and esterified cholesterol, phospholipids and triglycerides with whole plasma followed by chemical precipitation and radioactive counting in the supernatant (HDL). RESULTS: LDL and HDL cholesterol were similar in Group A and B, but group B had higher triglycerides (2.31±1.30 vs. 1.58±0.61 mmol/l, P<0.0001) and total and non-HDL unesterified cholesterol (36.3±7.8 vs. 33.9±5.9 mmol/l, P<0,05; 30.6±7.9 vs. 27.6±6.2 mmol/l, P<0,05; respectively) than group A and a non-significant trend to increased apolipoprotein B (103±20 vs. 97±20 mg/dl, P=0.08). 36 patients with the highest, ≥8.0% (64 mmol/mol), HbA1c also showed non-significant trend of elevated non-esterified fatty acids (NEFA) compared to 37 with lowest, ≤6.0% (42 mmol/mol), HbA1c (P=0.08). Patients with higher NEFA had higher triglycerides than those with lower NEFA levels (P<0.01).Transfers of all lipids from nanoemulsion to HDL and lipid composition of HDL were equal in both groups. CONCLUSIONS: For the first time it was shown that in addition to triglycerides, unesterified cholesterol is also a marker of poor glycemic control. In vitro HDL lipid transfers, an important aspect of HDL metabolism, were not related with the glycemic control.


Subject(s)
Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/therapeutic use , Lipid Metabolism/physiology , Lipids/blood , Aged , Blood Glucose/metabolism , Female , Glycated Hemoglobin/analysis , Humans , Male , Middle Aged
7.
Arq. bras. cardiol ; 101(3,supl.3): 1-95, set. 2013. tab
Article in Portuguese | LILACS, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: lil-689782
8.
Arq. bras. cardiol ; 101(2,supl.3): 1-221, ago. 2013. ilus, tab
Article in Portuguese | LILACS | ID: lil-685382
9.
Vasa ; 40(5): 390-7, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21948782

ABSTRACT

BACKGROUND: Exercise training is recommended as the first-line therapy for intermittent claudication patients. However, the effects of exercise therapy on cardiovascular function of these patients have been poorly studied. The aim of this study is to compare the effects of walking and strength training on cardiovascular responses assessed at rest and during exercise in patients with intermittent claudication. PATIENTS AND METHODS: Thirty-four patients with stable symptoms of intermittent claudication were randomized into two groups: strength training (ST) consisting of eight exercises, three sets of 10 repetitions, intensity of 11 - 13 on 15-grade Borg scale, 2-min interval between sets; and walking training (WT) consisting of walking on a treadmill, 15 bouts of 2-min, intensity of 11 - 13 on 15-grade Borg scale, with a 2-min interval between bouts. Before and after 12 weeks, blood pressure, heart rate and rate pressure product were measured at rest and during a progressive treadmill test until maximal claudication pain. RESULTS: Fifteen patients in each group completed the training program. After the training programs, resting systolic blood pressure (ST:-6 ± 13 mmHg and WT:-3 ± 18 mmHg, P = .04), heart rate (ST: -6 ± 10 bpm and WT:-2 ± 9 bpm, P = .03), and rate pressure product (ST:-1485 ± 1442 mmHg*bpm and WT:- 605 ± 2145 mmHg*bpm, P = .01) decreased significantly and similarly in both groups. Submaximal systolic blood pressure (ST: -14 ± 23 mmHg and WT:-6 ± 23 mmHg, P = .02), and rate pressure product (ST:-1579 ± 3444 mmHg*bpm and WT: -1264 ± 3005 mmHg*bpm, P = .04) decreased significantly and similarly in both groups. There were no changes in submaximal heart rate after ST and WT. Maximal systolic blood pressure, heart rate, and rate pressure product did not change in either group, although maximal exercise time increased similarly in the ST and WT groups (+31 ± 19 %, and +31 ± 32 %, respectively, P < .01). CONCLUSIONS: Strength and walking trainings promoted similar increases in walking capacity and decreases in resting and submaximal exercise cardiovascular load.


Subject(s)
Blood Pressure , Heart Rate , Intermittent Claudication/therapy , Peripheral Arterial Disease/therapy , Resistance Training , Walking , Analysis of Variance , Brazil , Chi-Square Distribution , Exercise Test , Humans , Intermittent Claudication/etiology , Intermittent Claudication/physiopathology , Peripheral Arterial Disease/complications , Peripheral Arterial Disease/physiopathology , Time Factors , Treatment Outcome
10.
Ann Oncol ; 21(12): 2333-2341, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20511340

ABSTRACT

BACKGROUND: The natural history and consequences of severe H1N1 influenza infection among cancer patients are not yet fully characterized. We describe eight cases of H1N1 infection in cancer patients admitted to the intensive care unit of a referral cancer center. PATIENTS AND METHODS: Clinical data from all patients admitted with acute respiratory failure due to novel viral H1N1 infection were reviewed. Lung tissue was submitted for viral and bacteriological analyses by real-time RT-PCR, and autopsy was conducted on all patients who died. RESULTS: Eight patients were admitted, with ages ranging from 55 to 65 years old. There were five patients with solid organ tumors (62.5%) and three with hematological malignancies (37.5%). Five patients required mechanical ventilation and all died. Four patients had bacterial bronchopneumonia. All deaths occurred due to multiple organ failure. A milder form of lung disease was present in the three cases who survived. Lung tissue analysis was performed in all patients and showed diffuse alveolar damage in most patients. Other lung findings were necrotizing bronchiolitis or extensive hemorrhage. CONCLUSIONS: H1N1 viral infection in patients with cancer can cause severe illness, resulting in acute respiratory distress syndrome and death. More data are needed to identify predictors of unfavorable evolution in these patients.


Subject(s)
Influenza A Virus, H1N1 Subtype , Influenza, Human/complications , Neoplasms/complications , Aged , Autopsy , Female , Humans , Influenza A Virus, H1N1 Subtype/genetics , Influenza A Virus, H1N1 Subtype/physiology , Influenza, Human/diagnostic imaging , Influenza, Human/mortality , Influenza, Human/pathology , Intensive Care Units , Male , Middle Aged , Multiple Organ Failure/etiology , Multiple Organ Failure/pathology , Neoplasms/diagnostic imaging , Neoplasms/mortality , Neoplasms/pathology , Radiography , Respiration, Artificial , Respiratory Distress Syndrome/diagnostic imaging , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/mortality , Respiratory Distress Syndrome/pathology , Retrospective Studies , Severity of Illness Index
11.
Clin Nephrol ; 71(4): 445-7, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19356379

ABSTRACT

Hypercalcemia is a life-threatening disorder and is related primarily to neoplastic diseases and primary and secondary hyperparathyroidism. The association of hypercalcemia and renal failure is frequent in the medical literature, although pathogenetic mechanisms remain to be elucidated. In this article, we present a case of hypercalcemia and acute renal failure secondary to vitamin D and vitamin A intoxication, after an over-the-counter intramuscular use by a young man starting an athletic performance program. A discussion of clinical picture, diagnosis and treatment is made, and we highlight the risk of pathological conditions triggered by inadvertent use of supplementation products and formulas available in health and fitness commercial centers.


Subject(s)
Acute Kidney Injury/chemically induced , Calcium/poisoning , Dietary Supplements/poisoning , Hypercalcemia/chemically induced , Hypervitaminosis A/chemically induced , Vitamin D/poisoning , Acute Kidney Injury/diagnosis , Adult , Diagnosis, Differential , Humans , Hypercalcemia/diagnosis , Male
12.
South Med J ; 92(1): 67-8, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9932831

ABSTRACT

A 61-year-old man with chest pain and fever was referred to our hospital. The physical examination and electrocardiogram were unrevealing. Laboratory tests showed leukocytosis, and echocardiography showed mild pericardial effusion. The patient died soon after hospital admission. Necropsy revealed ruptured mycotic aneurysm of the right coronary artery in the absence of infective endocarditis. Thus, mycotic aneurysm of the coronary artery may occur without infective endocarditis and may be clinically manifested as pericarditis and leukocytosis.


Subject(s)
Aneurysm, Infected , Aneurysm, Ruptured , Coronary Aneurysm , Aneurysm, Infected/complications , Aneurysm, Ruptured/complications , Coronary Aneurysm/complications , Fatal Outcome , Heart Diseases/complications , Heart Diseases/pathology , Hematoma/complications , Hematoma/pathology , Humans , Male , Middle Aged , Pericarditis/complications
13.
J Am Coll Cardiol ; 30(5): 1228-32, 1997 Nov 01.
Article in English | MEDLINE | ID: mdl-9350920

ABSTRACT

OBJECTIVES: We sought to investigate whether alterations in cardiac high energy phosphates occur in postischemic "stunned" human myocardium. BACKGROUND: Transient postischemic myocardial dysfunction is a common phenomenon that occurs in a variety of clinical settings in the absence of necrosis, and its pathogenesis is still unclear. Cardiac high energy phosphates are reduced during ischemia, and persistently altered myocardial high energy phosphate metabolism has been suggested as a mechanism contributing to stunning. METHODS: We studied 29 patients with a first anterior myocardial infarction (MI) who underwent successful reperfusion within 6 h of the onset of chest pain. These patients underwent 31P magnetic resonance spectroscopy (MRS) a mean of 4 days after MI for measurement of left ventricular contractility and relative high energy phosphate metabolites. Twenty-one patients underwent a second 31P MRS study a mean of 39 days after MI. Eight volunteers served as control subjects. RESULTS: Global and infarct area wall motion scores improved significantly between the early and late studies. No difference was found between early cardiac phosphocreatine (PCr)/beta-adenosine triphosphate (beta-ATP) ratios in patients and control subjects ([mean +/- SD] 1.51 +/- 0.17 vs. 1.61 +/- 0.18, respectively, p = 0.17) or between early and late study results in patients (1.51 +/- 0.17 vs. 1.53 +/- 0.17, respectively, p = 0.6). For alpha of 0.05, the study had a 90% power to detect a 9% difference. CONCLUSIONS: The results of this study demonstrate normal myocardial PCr/ATP ratios in patients with myocardial stunning after reperfusion and suggest that relative cardiac high energy phosphates are not depleted in stunned human myocardium.


Subject(s)
Adenosine Triphosphate/metabolism , Myocardial Stunning/metabolism , Myocardium/metabolism , Phosphocreatine/metabolism , Adult , Aged , Female , Humans , Magnetic Resonance Spectroscopy , Male , Middle Aged , Myocardial Stunning/physiopathology , Ventricular Function, Left
14.
Am J Cardiol ; 79(10): 1323-8, 1997 May 15.
Article in English | MEDLINE | ID: mdl-9165151

ABSTRACT

This study investigated both the in-hospital and long-term prognostic significance of ST-segment depression in non-infarct-related leads in patients who received thrombolytic therapy after acute myocardial infarction (AMI). We evaluated 221 consecutive patients who were admitted with their first AMI and underwent thrombolysis. Patients were followed for an average of 31 months and were classified into 3 groups: group 1 included 51 patients with persistent ST-segment depression, group 2 had 97 patients with transient ST-segment depression, and group 3 consisted of 73 patients without ST-segment depression (absent). Group 1 had significantly worse long-term survival during follow up by Kaplan-Meier analysis (55%) versus group 2 (81%) and group 3 (94%) (p = 0.0004) and higher event rates. This prognostic significance seemed to be maintained in both the anterior and inferior wall AMI groups. Multivariate analysis, using the Cox model, showed that Killip class, in-hospital left ventricular ejection fraction, and the persistence of ST-segment depression on the predischarge electrocardiogram (group 1) were independent predictors of survival. ST-segment depression in non-infarct-related leads on the predischarge electrocardiogram is an independent risk factor for worse long-term survival after anterior as well as inferior AMI treated with thrombolytic therapy.


Subject(s)
Electrocardiography , Myocardial Infarction/drug therapy , Myocardial Infarction/physiopathology , Thrombolytic Therapy , Disease-Free Survival , Female , Follow-Up Studies , Humans , Male , Middle Aged , Myocardial Infarction/mortality , Prognosis , Risk Factors , Statistics as Topic
15.
Arq. bras. cardiol ; 66(1): 11-14, jan. 1996. tab, graf
Article in Portuguese | LILACS | ID: lil-165735

ABSTRACT

Objetivo - Avaliar a influência do precondicionamento isquêmico no fenômeno do desenvolvimento de circulaçäo colateral (CC), na funçäo ventrícular precoce e na evoluçäo hospitalar de pacientes com infarto agudo do miocárdio (IAM). Métodos - Foram estudados 97 pacientes com IAM anterior nas primeiras 6h, com oclusäo proximal da artéria coronária descendente anterior e divididos em 2 grupos na dependência da presença (GA) ou ausência (GB) de angina precedendo o IAM. Coronariografia e ventriculografiaoram realizadas nas primeiras 6h , antes de qualquer tentativa de reperfusäo. A fraçäo de ejeçäo global do ventrículo esquerdo (FEVE), foi obtida através do método de áreas e a funçäo regional da parede anterior anterior através da linha do centro. Resultados - Os grupos foram superponíveis em relaçäo ao sexo, idade, pico de CKMB, tratamento instituído (perfusäo química ou mecânica) e sucesso na reperfusäo. A média da FEVE e a mobilidade da parede anterior foram similares nos 2 gupos, respectivamente, 3+_9 por cento e -2,55+/_1,17 dp/corda no GA e 37 por cento+/_8 por cento e -2,75+/_0,79 dp/corda no GB (p=ns). A CC esteve presente em 6 pacientes do GA e em 8 do GB (p=ns). A evoluçäo clínica foi melhor no GA (todos Killip classe 1) em comparçäo ao GB (8 pacientes Killip > ou igual a 2) p=0,007. Conclusäo - Embora näo exista diferença entre os grupos em relaçäo a presença de CC, funçäo ventricular e regional do ventrículo esquerdo, a presença de angina precedendo o infarto associado à melhor evoluçäo hsptalar, a qual poderia em parte ser explicada pelo fenômeno denominado precondicionamento esquêmico.


Subject(s)
Ventricular Function, Left , Myocardial Infarction
16.
Arq Bras Cardiol ; 65(3): 221-5, 1995 Sep.
Article in Portuguese | MEDLINE | ID: mdl-8579508

ABSTRACT

PURPOSE: Long term clinical and hemodynamic benefits of dynamic cardiomyoplasty (DC) have been reported. However, no information is available about long-term morphological changes in the wrapped latissimus dorsi (LD) muscle in humans. METHODS: The latissimus dorsi muscle flap was evaluated by magnetic resonance imaging (MRI) in 5 patients submitted to DC for treatment of severe dilated cardiomyopathy. All patients were studied from 24 to 52 months after the surgical procedure at the time of the cardiomyostimulator replacement. In the interim, LD was stimulated with burst of 6 pulses (burst duration 185 msec, burst freq 30Hz) synchronized to every cardiac contraction with a maximum of 100 LD contractions/min. Images were acquired on a GE Sigma 1.5 T system (TE = 25ms, TR = R- Rx2, slice thickness 8mm). RESULTS: The thickness of was 7.6 +/- 0.8mm. In addition, the signal intensity of the LD was compared with that of thoracic skeletal muscle and was found to be increased (2.19 +/- 0.42). The signal intensity was similar to that of subcutaneous fat in those images. CONCLUSION: Morphologic changes in the wrapped LD muscle consistent with fatty degeneration occur after DC and can be detected by MRI. Further studies will be necessary to demonstrate the clinical significance of such LD muscle flap changes.


Subject(s)
Cardiomyopathies/surgery , Cardiomyoplasty , Magnetic Resonance Imaging , Muscle, Skeletal/pathology , Adult , Cardiomyopathies/physiopathology , Humans , Male , Middle Aged , Muscle Contraction , Muscle, Skeletal/physiopathology
17.
Arq Bras Cardiol ; 65(2): 125-8, 1995 Aug.
Article in Portuguese | MEDLINE | ID: mdl-8554487

ABSTRACT

PURPOSE: To determine the patency and incidence rates of left circumflex coronary artery (LCX) as the infarct related artery (IRA) in Q-wave and non-Q wave acute myocardial infarction (AMI). METHODS: Two-hundreds and twenty one patients (172 men) with AMI were stratified in Q and non-Q waves groups. All patients were submitted to cinecoronary angiography 72 hours after the beginning of symptoms and the IRA and its patency were evaluated. RESULTS: In non-Q wave AMI, the LCX was considered to be the IRA in 35% of the patients. In Q wave AMI, this incidence was 8% (p < 0.001). Occlusion of LCX was seen in all non-Q wave AMI patients when it was the IRA. CONCLUSION: The incidence of LCX as IRA was significantly higher in non-Q wave AMI patients. This group did not have the previously expected greater patency rates, what could result in different clinical and evolutive characteristics.


Subject(s)
Coronary Disease/complications , Coronary Disease/diagnosis , Myocardial Infarction/diagnosis , Chi-Square Distribution , Coronary Angiography , Electrocardiography , Female , Humans , Male , Myocardial Infarction/etiology , Myocardial Infarction/physiopathology , Retrospective Studies
18.
Arq Bras Cardiol ; 64(5): 435-8, 1995 May.
Article in Portuguese | MEDLINE | ID: mdl-8526773

ABSTRACT

PURPOSE: To evaluate the importance of the right coronary artery (RCA) patency in patients with right ventricular infarction. METHODS: Fifty-two patients with inferior wall myocardial infarction and right ventricular involvement were studied and divided in two groups: group A (GA) included 35 patients in whom the RCA was patent at coronary angiography, and group B (GB), 17 who had an occluded RCA. They were prospectively evaluated for electrical and hemodynamic complications, as well as in-hospital mortality. RESULTS: The mortality in GA was 11% and 29% in GB, p = 0.13; electrical complications were 11% in GA and 35% in GB, p = 0.06; hemodynamic complications were 8% in GA and 41% in GB, p = 0.009. CONCLUSION: These findings suggest a trend towards reduction in mortality and electrical complications, and significant reduction of hemodynamic complications in patients with inferior wall myocardial infarction with involvement of the right ventricle who have the RCA patent. Thus, RCA patency appears to be important in determining in-hospital outcomes of these patients.


Subject(s)
Coronary Vessels/physiopathology , Myocardial Infarction/physiopathology , Vascular Patency/physiology , Female , Heart Ventricles/physiopathology , Humans , Length of Stay , Male , Middle Aged , Myocardial Infarction/complications , Prognosis
19.
Sao Paulo Med J ; 113(2): 880-3, 1995.
Article in English | MEDLINE | ID: mdl-8650491

ABSTRACT

Many important aspects of Chagas' heart disease can be successfully assessed using magnetic resonance imaging of the heart. It is possible to obtain with great detail the anatomic characterization of the cardiac as well as important information of the functional or metabolic status of the heart. Magnetic resonance imaging after gadolinium infusion seems also a promising technique to obtain a better regional characterization of myocardial tissue, and may be important in the non-invasive diagnosis of active myocarditis in patients with Chagas' heart disease.


Subject(s)
Chagas Cardiomyopathy/diagnosis , Humans , Magnetic Resonance Imaging
20.
Arq Bras Cardiol ; 64(3): 221-4, 1995 Mar.
Article in Portuguese | MEDLINE | ID: mdl-7487508

ABSTRACT

PURPOSE: To determine the value of magnetic resonance imaging (MRI) in the noninvasive detection of infarct related coronary artery patency after thrombolysis. METHODS: We studied 26 patients with acute myocardial infarction submitted to thrombolysis underwent MRI studies before and after 0.1mmol/kg gadolinium-DTPA injection within the first 48 h of MI. Signal intensity was assessed by circumferential profile analysis techniques. RESULTS: The average ratio of signal intensity of infarcted tissue over normal myocardium (I/N) was significantly higher in patients with patent arteries (1.3 +/- 0.13 vs 1.12 +/- 0.07, p < 0.02). Compared to coronariography MRI, sensitivity of 81% and specificity of 100% for the diagnosis of coronary patency. CONCLUSION: Gadolinium infusion increased infarcted and normal myocardium differentiation. The study of gadolinium kinetics at MRI is a promising technique for noninvasive diagnosis of coronary patency.


Subject(s)
Coronary Vessels/pathology , Magnetic Resonance Imaging , Myocardial Infarction/drug therapy , Myocardial Infarction/pathology , Thrombolytic Therapy , Vascular Patency , Aged , Contrast Media , Gadolinium DTPA , Humans , Middle Aged , Organometallic Compounds , Pentetic Acid/analogs & derivatives , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...